Aarti Drugs Limited (NSE:AARTIDRUGS) — Stock Price

Rs422.55 INR
▲ 1.53% today

Aarti Drugs Limited (NSE:AARTIDRUGS) is currently trading at Rs422.55 INR, up 1.53% today. Over the past 52 weeks, shares have ranged between Rs319.75 and Rs525.35. This page tracks Aarti Drugs Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Aarti Drugs Limited.

Aarti Drugs Limited (AARTIDRUGS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Aarti Drugs Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Aarti Drugs Limited Income Statement — Revenue, Profit & Earnings by Year

Aarti Drugs Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs23.87 Billion Rs25.29 Billion Rs27.16 Billion Rs24.89 Billion Rs21.55 Billion
Cost of Revenue Rs15.42 Billion Rs16.78 Billion Rs18.89 Billion Rs21.00 Billion Rs15.54 Billion
Gross Profit Rs8.45 Billion Rs8.51 Billion Rs3.69 Billion Rs3.89 Billion Rs6.00 Billion
Research & Development Rs130.42 Million Rs120.21 Million Rs94.38 Million Rs78.21 Million Rs85.97 Million
SG&A Rs1.12 Billion Rs1.02 Billion Rs921.40 Million Rs827.03 Million Rs805.56 Million
Total Operating Expenses Rs1.12 Billion Rs1.17 Billion Rs1.04 Billion Rs2.06 Billion Rs2.05 Billion
Operating Income Rs7.33 Billion Rs2.69 Billion Rs2.65 Billion Rs2.88 Billion Rs3.96 Billion
EBITDA Rs2.87 Billion Rs3.25 Billion Rs3.12 Billion Rs3.44 Billion Rs4.42 Billion
EBIT Rs2.31 Billion Rs2.73 Billion Rs2.61 Billion Rs2.94 Billion Rs3.92 Billion
Interest Expense Rs358.70 Million Rs378.88 Million Rs371.38 Million Rs239.08 Million Rs262.31 Million
Income Before Tax Rs2.12 Billion Rs2.36 Billion Rs2.24 Billion Rs2.70 Billion Rs3.69 Billion
Income Tax Expense Rs436.80 Million Rs639.37 Million Rs578.20 Million Rs649.59 Million Rs886.16 Million
Net Income Rs1.68 Billion Rs1.71 Billion Rs1.66 Billion Rs2.05 Billion Rs2.80 Billion

Aarti Drugs Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Aarti Drugs Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs25.75 Billion Rs24.32 Billion Rs24.21 Billion Rs22.08 Billion Rs17.66 Billion
Total Current Assets Rs13.38 Billion Rs13.21 Billion Rs14.92 Billion Rs13.93 Billion Rs10.57 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs150.50 Million Rs21.86 Million Rs122.10 Million Rs126.40 Million Rs122.05 Million
Net Receivables Rs7.52 Billion Rs7.05 Billion Rs8.65 Billion Rs7.63 Billion Rs5.78 Billion
Inventory Rs4.73 Billion Rs4.86 Billion Rs5.16 Billion Rs5.26 Billion Rs4.15 Billion
Property, Plant & Equipment — — Rs8.86 Billion Rs7.67 Billion Rs6.84 Billion
Goodwill — Rs-58.00K Rs8.00K — —
Total Liabilities Rs12.05 Billion Rs11.50 Billion Rs12.29 Billion Rs11.72 Billion Rs8.53 Billion
Total Current Liabilities Rs8.37 Billion Rs7.96 Billion Rs9.33 Billion Rs9.40 Billion Rs5.95 Billion
Long-term Debt Rs2.84 Billion Rs2.75 Billion Rs2.05 Billion Rs1.39 Billion Rs1.48 Billion
Net Debt Rs6.08 Billion Rs5.58 Billion Rs6.00 Billion Rs5.21 Billion Rs3.42 Billion
Total Stockholder Equity Rs13.69 Billion Rs12.82 Billion Rs11.92 Billion Rs10.36 Billion Rs9.13 Billion
Retained Earnings Rs12.40 Billion Rs11.55 Billion Rs10.21 Billion Rs8.79 Billion Rs7.54 Billion

Aarti Drugs Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Aarti Drugs Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs2.45 Billion Rs3.59 Billion Rs1.34 Billion Rs696.36 Million Rs1.55 Billion
Capital Expenditures Rs1.77 Billion Rs2.26 Billion Rs1.65 Billion Rs1.52 Billion Rs881.31 Million
Free Cash Flow Rs674.20 Million Rs1.33 Billion Rs-304.70 Million Rs-823.39 Million Rs667.19 Million
Investing Cash Flow Rs-1.65 Billion Rs-2.24 Billion Rs-1.64 Billion Rs-1.49 Billion Rs-716.79 Million
Financing Cash Flow Rs-821.20 Million Rs-1.36 Billion Rs165.40 Million Rs920.25 Million Rs-811.29 Million
Dividends Paid Rs90.60 Million Rs92.67 Million Rs94.00 Million Rs95.08 Million Rs232.05 Million
Stock-Based Compensation — — — — —
Depreciation Rs557.80 Million Rs514.47 Million Rs503.20 Million Rs500.49 Million Rs498.83 Million
Change in Cash Rs-21.63 Million Rs-7.61 Million Rs-132.30 Million Rs127.99 Million Rs20.42 Million

Aarti Drugs Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Aarti Drugs Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 04, 2026 — — —
Jan 27, 2026 — — —
Nov 07, 2025 4.95 4.90 +1.02%
Jul 24, 2025 — — —
May 06, 2025 — — —
Jan 22, 2025 — — —
Oct 23, 2020 8.07 5.78 +39.62%
Jul 25, 2020 9.17 2.90 +216.21%